Navigation Links
Take the Skyhook Challenge and Help Beat Blood Cancer
Date:4/8/2013

WHITE PLAINS, N.Y., April 8, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Novartis are teaming up to raise awareness about Ph+ chronic myeloid leukemia (CML), the blood cancer that National Basketball Hall of Famer Kareem Abdul-Jabbar was diagnosed with in 2008.

During half-time at the April 9 Los Angeles Lakers game at the Staples Center, Abdul-Jabbar will take center court for the first shot in the "CML Skyhook Challenge," starting the countdown clock to raise $38,387, matching his NBA-leading life-time record of 38,387 points in 1,560 games.

Abdul-Jabbar will be joined by a group of fellow CML survivors, who will be invited to the game and to join the half-time festivities. The basketball legend will encourage fans at the game and at home to play the Skyhook Challenge via their mobile devices. By texting KAJ to 72645 participants will receive a series of questions about CML, Abdul-Jabbar's career and LLS. The game will also be available online at www.skyhookchallenge.com. Each correct answer is worth one point; players can answer more than one question. Once the Challenge registers 38,387 points, Novartis will donate $38,387 to LLS to support blood cancer research and patient services. The contest will take place until the total fundraising goal is reached. LLS is encouraging supporters to not only play the game but to keep the fundraising going by donating online at www.lls.org/skyhookchallenge.

"We are thrilled to have the support of legendary basketball star Kareem Abdul-Jabbar to help us raise awareness about blood cancers and the important work being done by The Leukemia & Lymphoma Society," said Lisa Stockmon , LLS executive vice president and chief marketing officer. "Kareem's message of hope is so inspirational and will help us bring more attention to the urgent need to fund research for breakthrough therapies, the only way we can achieve our goal of realizing a world without blood cancers."

Since being diagnosed, Abdul-Jabbar has been a strong advocate for CML patients, encouraging them to understand their treatment milestones and actively talk to their physicians to ensure their disease is properly managed. Ph+ CML is characterized by an abnormality known as the Philadelphia chromosome, which produces a protein called Bcr-Abl, identified as the sole cause and driver of CML. 

"Thanks to research, survival rates have doubled, tripled and even quadrupled for some blood cancers, but there is still critical unmet medical need, and more research is needed to advance therapies that save more lives," said LLS President and Chief Executive Officer John Walter .

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. 

Contact: Andrea Greif
914.821.8958
andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
2. Quiz that Challenges People to Learn if Their Bodies are Toxic is Posted on TimetoCleanse.com
3. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
4. ERISA Creates Benchmarking Challenges for Plan Sponsors
5. Safe in Commons "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
6. FDA Publicly Challenged to Support Unsubstantiated Claims Regarding Electronic Cigarettes
7. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
8. Survey Suggests Rural Seniors Face Challenges from Medicare Part D Preferred Pharmacy Drug Plans
9. Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
10. Interventional Cardiologists Cautious in Adopting Intravascular Imaging and Assessment Devices: Challenge to Manufacturers
11. As Type 2 Diabetes Grows at Alarming Rates, Pharmaceutical Companies Will Face New Challenges and New Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):